Primrose Bio is exhibiting and presenting at the 13th International mRNA Health Conference, taking place November 11–13, 2025, in Berlin. This annual gathering of mRNA leaders brings together cutting-edge research and industry insight, and we’re excited to contribute across multiple formats.
You can find us at Booth #10 at the InterContinental Hotel Berlin, where our team is available to discuss how our engineered enzymes are enabling faster, more scalable, and cost-effective mRNA manufacturing.
Speaking Session
On Wednesday, November 13 at 9:55 AM, Helge Zieler, PhD, Chief Technology Officer at Primrose Bio, presents in Session XIII – Manufacturing. His talk, “No Compromises: Engineered RNA Polymerases for High-Quality, Low-Cost mRNA Manufacturing,” highlights how our enzyme platform drives yield, purity, and process efficiency without trade-offs.
Poster Presentation
On Tuesday, November 11, Sabrina Baffert, Director of Molecular Biology, presents Poster #91:
“Prima RNApols™: Engineered Enzymes Powering the Future of mRNA Therapeutics,” featuring new data on enzyme performance and scalability.
